PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
CCL3 1,427 Target Target CXCL10 2,386 238 0.13 -0.87 0.17 0.83
CCL3 1,427 Target Target CXCL2 750 123 0.12 -0.87 0.16 0.83
Tissue-Type Plasminogen Activator 5,020 Target Target Urokinase-Type Plasminogen Activator 3,939 603 0.14 -0.86 0.15 0.83
CRG-2 41 Target Target CRG-10 2 1 0.11 -0.70 0.50 0.83
CCL5 2,002 Target Target CXCL9 1,016 180 0.13 -0.87 0.18 0.83
CCL4 5,638 Target Target CCL3 1,427 535 0.19 -0.75 0.37 0.83
Epigen 27 Target Target beta-Cellulin 17 1 0.05 -0.95 0.06 0.83
EPHB4 329 Target Target EPHB3 118 18 0.09 -0.90 0.15 0.82
BD2 76 Target Target BD4 26 3 0.07 -0.92 0.12 0.82
Epidermal Growth Factor Receptor 24,772 Target Target EGF 27,487 4,679 0.18 -0.82 0.19 0.82
CCL7 274 Target Target CCL1 220 17 0.07 -0.93 0.08 0.82
Acute Promyelocytic Leukemia 4,780 Disease Target Retinoic Acid Receptor Alpha 1,068 413 0.18 -0.75 0.39 0.82
BMP-7 1,112 Target Target BMP-2 3,889 338 0.16 -0.80 0.30 0.82
CXCL10/IP-10 114 Target Target CXCL11 526 27 0.11 -0.85 0.24 0.82
CXCL7 76 Target Target CCL14 34 3 0.06 -0.94 0.09 0.82
CXCL9 1,016 Target Target CCL3 1,427 117 0.10 -0.90 0.12 0.82
EPHA4 357 Target Target EPHB2 385 25 0.07 -0.93 0.07 0.82
CCL18 256 Target Target DC-CK1 22 9 0.12 -0.76 0.41 0.82
EPHB3 118 Target Target EPHA3 140 7 0.05 -0.95 0.06 0.82
ApoE4 1,525 Target Target APOE 12,771 1,119 0.25 -0.49 0.73 0.82
EPHA4 357 Target Target EPHA3 140 18 0.08 -0.91 0.13 0.82
CXCL3 145 Target Target CCL8 197 10 0.06 -0.94 0.07 0.82
CXCL10/IP-10 114 Target Target CXCL10 2,386 114 0.22 -0.09 1.00 0.82
Alpha-2a Adrenergic Receptor 188 Target Target Alpha-2c Adrenergic Receptor 42 7 0.08 -0.90 0.17 0.82
ERK1 18,374 Target Target ERK2 3,287 1,788 0.23 -0.64 0.54 0.82
CCL8 197 Target Target CCL1 220 11 0.05 -0.95 0.06 0.81
Angiotensin Converting Enzyme 31,674 Target Target Renin 43,456 6,899 0.19 -0.81 0.22 0.81
Alpha-Amylase 7,171 Target Target Pancreatic Alpha-Amylase 423 423 0.24 -0.05 1.00 0.81
CAMK2A 42 Target Target ADRBK1 10 1 0.05 -0.94 0.10 0.81
EPHA4 357 Target Target EPHA2 532 29 0.07 -0.93 0.08 0.81
CCL14 34 Target Target Eotaxin-3/CCL26 26 1 0.03 -0.97 0.04 0.81
DAPK2 27 Target Target DAPK1 205 6 0.08 -0.87 0.22 0.81
CCL14 34 Target Target CCL8 197 6 0.07 -0.89 0.18 0.81
Des (1-3) IGF-I 191 Target Target Des (1-6) IGF-II 18 5 0.09 -0.84 0.28 0.81
CXCL7 76 Target Target CCL8 197 7 0.06 -0.94 0.09 0.81
Epigen 27 Target Target Epiregulin 291 8 0.09 -0.83 0.30 0.81
Artemin 184 Target Target Enovin 3 3 0.13 -0.50 1.00 0.81
EPHB4 329 Target Target EPHB1 137 13 0.06 -0.93 0.09 0.81
Cathepsin G 1,613 Target Target Elastase 13,875 985 0.21 -0.60 0.61 0.81
EPHA4 357 Target Target EPHB1 137 14 0.06 -0.93 0.10 0.81
CCL7 274 Target Target CCL2 3,560 164 0.17 -0.62 0.60 0.81
CCN5 57 Target Target CYR61 539 17 0.10 -0.82 0.30 0.81
Antithrombin 13,773 Target Target D-Dimer 6,185 1,337 0.14 -0.84 0.22 0.81
CCL7 274 Target Target CXCL2 750 34 0.08 -0.91 0.12 0.81
Cytokeratin 8 587 Target Target Cytokeratin 18 1,108 60 0.07 -0.92 0.10 0.81
CXCL10/IP-10 114 Target Target CXCL9 1,016 37 0.11 -0.81 0.32 0.81
CAMK2D 21 Target Target CAMK4 43 1 0.03 -0.96 0.05 0.80
BMX 185 Target Target BTK 1,263 49 0.10 -0.84 0.26 0.80
CCL7 274 Target Target CXCL3 145 10 0.05 -0.95 0.07 0.80
EPHA3 140 Target Target EPHB1 137 5 0.04 -0.96 0.04 0.80